ADCY8 and type 2 diabetes mellitus: While the supplement described in the study did not reduce serum levels of glycemia and HbAc1, it demonstrated the safety of using such molecules in patients with T2DM; furthermore, it did not interfere with background diabetic parameters, nor did it impair glycemic parameters.